Insulin resistance predicts brain amyloid deposition in late middle-aged adults

Alzheimer's and Dementia

Volumn 11, Issue 5, 2015, Pages 504-510.e1

  Willette, Auriel A ^a,b,c   Johnson, Sterling C ^a,b,d   Birdsill, Alex C ^a,b   Sager, Mark A ^b   Christian, Bradley ^b   Baker, Laura D ^e   Craft, Suzanne ^e   Oh, Jennifer ^a,b   Statz, Eric ^a,b   Hermann, Bruce P ^b   Jonaitis, Erin M ^b   Koscik, Rebecca L ^b   La Rue, Asenath ^b   Asthana, Sanjay ^a,b   Bendlin, Barbara B ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cognitively normal; Insulin resistance; PiB; Prefrontal

Indexed keywords

AMYLOID; PITTSBURGH COMPOUND B; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; APOLIPOPROTEIN E; THIAZOLE DERIVATIVE;

ADULT; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VOLUME OF DISTRIBUTION RATIO; AGED; BODY MASS; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; MENTAL HEALTH; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; THREE DIMENSIONAL IMAGING;

AGED; AMYLOID; ANILINE COMPOUNDS; APOLIPOPROTEINS E; BODY MASS INDEX; BRAIN; FEMALE; HUMANS; HYPERGLYCEMIA; IMAGING, THREE-DIMENSIONAL; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; THIAZOLES;

EID: 84929295476     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.03.011     Document Type: Article

References (40)

1. S.M. de la Monte, and J.R. Wands Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease J Alzheimers Dis 7 2005 45 61
2. L. Arab, R. Sadeghi, D.G. Walker, L.F. Lue, and M.N. Sabbagh Consequences of aberrant insulin regulation in the brain: can treating diabetes be effective for Alzheimer's disease Curr Neuropharmacol 9 2011 693 705
3. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci U S A 100 2003 4162 4167
4. L. Ho, W. Qin, P.N. Pompl, Z. Xiang, J. Wang, and Z. Zhao Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease Faseb J 18 2004 902 904
5. L. Zhao, B. Teter, T. Morihara, G.P. Lim, S.S. Ambegaokar, and O.J. Ubeda Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention J Neurosci 24 2004 11120 11126
6. S. Craft, B. Cholerton, and L.D. Baker Insulin and Alzheimer's disease: untangling the web J Alzheimers Dis 33 Suppl 1 2013 S263 S275
7. E.M. Schrijvers, J.C. Witteman, E.J. Sijbrands, A. Hofman, P.J. Koudstaal, and M.M. Breteler Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study Neurology 75 2010 1982 1987
8. K. Talbot, H.Y. Wang, H. Kazi, L.Y. Han, K.P. Bakshi, and A. Stucky Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J Clin Invest 122 2012 1316 1338
9. S.M. de la Monte Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease Drugs 72 2012 49 66
10. M.A. Reger, G.S. Watson, P.S. Green, C.W. Wilkinson, L.D. Baker, and B. Cholerton Intranasal insulin improves cognition and modulates beta-amyloid in early AD Neurology 70 2008 440 448
11. A.A. Willette, G. Xu, S.C. Johnson, A.C. Birdsill, E.M. Jonaitis, and M.A. Sager Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults Diabetes care 36 2013 443 449
12. C. Benedict, S.J. Brooks, J. Kullberg, J. Burgos, M.J. Kempton, and R. Nordenskjold Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly Diabetes care 35 2012 488 494
13. L.D. Baker, D.J. Cross, S. Minoshima, D. Belongia, G.S. Watson, and S. Craft Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes Arch Neurol 68 2011 51 57
14. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
15. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B Ann Neurol 55 2004 306 319
16. M.A. Sager, B. Hermann, and A. La Rue Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention J Geriatr Psychiatry Neurol 18 2005 245 249
17. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., and C.H. Kawas The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
18. S.C. Johnson, B.T. Christian, O.C. Okonkwo, J.M. Oh, S. Harding, and G. Xu Amyloid burden and neural function in people at risk for Alzheimer's disease Neurobiol Aging 35 2014 576 584
19. Spreen O, Strauss E A compendium of neuropsychological tests: administration, norms, and commentary A compendium of neuropsychological tests: administration, norms, and commentary, 2nd ed. Oxford, UK: Oxford University Press; 1998.
20. D. Wechsler WAIS-III: Wechsler Adult Intelligence Scale WAIS-III: Wechsler Adult Intelligence Scale Place 1997 Psychological Corporation
21. M.R. Trenerry Stroop Neuropsychological Screening Test manual Stroop Neuropsychological Screening Test manual place 1989 Psychological Assessment Resources
22. R.M. Reitan, and D. Wolfson The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation place 1993 Neuropsychology Press
23. M.W. Weiner, P.S. Aisen, C.R. Jack Jr., W.J. Jagust, J.Q. Trojanowski, and L. Shaw The Alzheimer's disease neuroimaging initiative: progress report and future plans Alzheimers Dement 6 2010 202 211.e7
24. S.C. Johnson, A. La Rue, B.P. Hermann, G. Xu, R.L. Koscik, and E.M. Jonaitis The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3/epsilon3 genotype Alzheimers Dement 7 2011 456 465
25. B. Fischl, A. van der Kouwe, C. Destrieux, E. Halgren, F. Segonne, and D.H. Salat Automatically parcellating the human cerebral cortex Cereb Cortex 14 2004 11 22
26. A.A. Wilson, A. Garcia, L. Jin, and S. Houle Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method Nucl Med Biol 27 2000 529 532
27. B.T. Christian, N.T. Vandehey, J.M. Floberg, and C.A. Mistretta Dynamic PET denoising with HYPR processing J Nucl Med 51 2010 1147 1154
28. B.J. Lopresti, W.E. Klunk, C.A. Mathis, J.A. Hoge, S.K. Ziolko, and X. Lu Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: a comparative analysis J Nucl Med 46 2005 1959 1972
29. J. Logan, J.S. Fowler, N.D. Volkow, G.J. Wang, Y.S. Ding, and D.L. Alexoff Distribution volume ratios without blood sampling from graphical analysis of PET data J Cereb Blood Flow Metab 16 1996 834 840
30. S. Holm A simple sequentially rejective multiple test procedure Scand J Statist 6 1979 65 70
31. G.D. Rabinovici, and W.J. Jagust Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo Behav Neurol 21 2009 117 128
32. M. Thambisetty, E. Jeffrey Metter, A. Yang, H. Dolan, C. Marano, and A.B. Zonderman Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging JAMA neurology 70 2013 1167 1172
33. H.B. Schioth, S. Craft, S.J. Brooks, W.H. Frey 2nd, and C. Benedict Brain insulin signaling and Alzheimer's disease: current evidence and future directions Mol Neurobiol 46 2012 4 10
34. S. Craft, and G.S. Watson Insulin and neurodegenerative disease: shared and specific mechanisms Lancet Neurol 3 2004 169 178
35. S. Hoyer The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review J Neural Transm 109 2002 991 1002
36. I.V. Murray, J.F. Proza, F. Sohrabji, and J.M. Lawler Vascular and metabolic dysfunction in Alzheimer's disease: a review Exp Biol Med (Maywood) 236 2011 772 782
37. J.E. Tooke, and K.L. Goh Endotheliopathy precedes type 2 diabetes Diabetes care 21 1998 2047 2049
38. A. Convit Links between cognitive impairment in insulin resistance: an explanatory model Neurobiol Aging 26 Suppl 1 2005 31 35
39. E.M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu, and W. Lee Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Proc Natl Acad Sci U S A 106 2009 6820 6825
40. J.C. Morris, C.M. Roe, C. Xiong, A.M. Fagan, A.M. Goate, and D.M. Holtzman APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging Ann Neurol 67 2010 122 131